First Department of Medicine, University of Szeged, H6720 Szeged, Hungary.
HAS-USZ Momentum Epithelial Cell Signaling and Secretion Research Group, University of Szeged, H6720 Szeged, Hungary.
Int J Mol Sci. 2020 Jun 3;21(11):4005. doi: 10.3390/ijms21114005.
Intracellular Ca signalling is a major signal transductional pathway in non-excitable cells, responsible for the regulation of a variety of physiological functions. In the secretory epithelial cells of the exocrine pancreas, such as acinar and ductal cells, intracellular Ca elevation regulates digestive enzyme secretion in acini or fluid and ion secretion in ductal cells. Although Ca is a uniquely versatile orchestrator of epithelial physiology, unregulated global elevation of the intracellular Ca concentration is an early trigger for the development of acute pancreatitis (AP). Regardless of the aetiology, different forms of AP all exhibit sustained intracellular Ca elevation as a common hallmark. The release of endoplasmic reticulum (ER) Ca stores by toxins (such as bile acids or fatty acid ethyl esters (FAEEs)) or increased intrapancreatic pressure activates the influx of extracellular Ca via the Orai1 Ca channel, a process known as store-operated Ca entry (SOCE). Intracellular Ca overload can lead to premature activation of trypsinogen in pancreatic acinar cells and impaired fluid and HCO secretion in ductal cells. Increased and unbalanced reactive oxygen species (ROS) production caused by sustained Ca elevation further contributes to cell dysfunction, leading to mitochondrial damage and cell death. Translational studies of AP identified several potential target molecules that can be modified to prevent intracellular Ca overload. One of the most promising drugs, a selective inhibitor of the Orai1 channel that has been shown to inhibit extracellular Ca influx and protect cells from injury, is currently being tested in clinical trials. In this review, we will summarise the recent advances in the field, with a special focus on the translational aspects of the basic findings.
细胞内 Ca 信号转导是无兴奋细胞的主要信号转导途径,负责调节各种生理功能。在胰腺的外分泌上皮细胞中,如腺泡和导管细胞,细胞内 Ca 升高调节腺泡中的消化酶分泌或导管细胞中的液体和离子分泌。尽管 Ca 是上皮生理学的独特多功能调节剂,但细胞内 Ca 浓度的不受调节的整体升高是急性胰腺炎 (AP) 发展的早期触发因素。无论病因如何,不同形式的 AP 都表现出持续的细胞内 Ca 升高作为共同特征。内质网 (ER) Ca 库的释放通过毒素(如胆汁酸或脂肪酸乙酯 (FAEE))或胰内压升高,激活 Orai1 Ca 通道的细胞外 Ca 内流,这一过程称为储存操纵的 Ca 进入 (SOCE)。细胞内 Ca 过载可导致胰腺腺泡细胞中胰蛋白酶原过早激活,并损害导管细胞中的液体和 HCO 分泌。持续 Ca 升高引起的活性氧 (ROS) 产生增加和失衡进一步导致细胞功能障碍,导致线粒体损伤和细胞死亡。AP 的转化研究确定了几种可以修饰的潜在靶分子,以防止细胞内 Ca 过载。最有前途的药物之一是 Orai1 通道的选择性抑制剂,已证明该抑制剂可抑制细胞外 Ca 内流并保护细胞免受损伤,目前正在临床试验中进行测试。在这篇综述中,我们将总结该领域的最新进展,特别关注基础发现的转化方面。